This study tests a drug called ampreloxetine in about 100 adults with multiple system atrophy (MSA) who have severe dizziness or fainting when standing due to low blood pressure. The goal is to see if the drug safely reduces these symptoms over 20 weeks. Participants first receiv…
Phase: PHASE3 • Sponsor: Theravance Biopharma • Aim: Symptom relief
Last updated May 18, 2026 12:13 UTC